277 related articles for article (PubMed ID: 36959665)
21. Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer.
Jin L; Mei W; Liu X; Sun X; Xin S; Zhou Z; Zhang J; Zhang B; Chen P; Cai M; Ye L
Front Immunol; 2022; 13():974034. PubMed ID: 36203594
[TBL] [Abstract][Full Text] [Related]
22. Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma.
Shan J; Geng R; Zhang Y; Wei J; Liu J; Bai J
Comput Biol Med; 2022 Oct; 149():105988. PubMed ID: 36007289
[TBL] [Abstract][Full Text] [Related]
23. Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC.
Wang Y; Zhang Y; Wang L; Zhang N; Xu W; Zhou J; Zhao Y; Zhu W; Zhang T; Wang L
Hepatol Int; 2022 Dec; 16(6):1435-1447. PubMed ID: 36065073
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
Front Genet; 2023; 14():1094793. PubMed ID: 36891150
[No Abstract] [Full Text] [Related]
25. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
Chen X; Hu G; Xiong L; Xu Q
Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
[No Abstract] [Full Text] [Related]
26. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine.
Huang X; Chen Z; Xiang X; Liu Y; Long X; Li K; Qin M; Long C; Mo X; Tang W; Liu J
EPMA J; 2022 Dec; 13(4):671-697. PubMed ID: 36505892
[TBL] [Abstract][Full Text] [Related]
27. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs.
Tu H; Zhang Q; Xue L; Bao J
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481
[TBL] [Abstract][Full Text] [Related]
28. Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma.
Liu H
Cancer Genet; 2023 Jun; 274-275():21-25. PubMed ID: 36963335
[TBL] [Abstract][Full Text] [Related]
29. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
30.
Wu L; Liu Y; Deng W; Wu T; Bu L; Chen L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629087
[TBL] [Abstract][Full Text] [Related]
31. Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer.
Sha S; Si L; Wu X; Chen Y; Xiong H; Xu Y; Liu W; Mei H; Wang T; Li M
Front Immunol; 2022; 13():922780. PubMed ID: 35979353
[TBL] [Abstract][Full Text] [Related]
32. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance.
Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q
Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125
[TBL] [Abstract][Full Text] [Related]
33. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
34. Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy.
Lai H; Xiang X; Long X; Chen Z; Liu Y; Huang X
Expert Rev Mol Diagn; 2024; 24(1-2):107-121. PubMed ID: 38288973
[TBL] [Abstract][Full Text] [Related]
35. Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
Li Z; Zhang H; Wang X; Wang Q; Xue J; Shi Y; Wang M; Wang G; Zhang J
Front Immunol; 2022; 13():996836. PubMed ID: 36059516
[TBL] [Abstract][Full Text] [Related]
36. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
Front Immunol; 2022; 13():998236. PubMed ID: 36110851
[TBL] [Abstract][Full Text] [Related]
37. Cuproptosis-related lncRNAs ovarian cancer: Multi-omics analysis of molecular mechanisms and potential therapeutic targets.
Wang Y; Liang Q; Xu L; Xiong J; Gao K; Xu P; Huang W
Environ Toxicol; 2024 Mar; 39(3):1650-1665. PubMed ID: 38019212
[TBL] [Abstract][Full Text] [Related]
38. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
Wang L; Yao B; Yang J; Tian Z; He J
BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.
Jiang ZR; Yang LH; Jin LZ; Yi LM; Bing PP; Zhou J; Yang JS
Front Oncol; 2022; 12():988680. PubMed ID: 36203428
[TBL] [Abstract][Full Text] [Related]
40. Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma.
Liu X; Sun B; Yao Y; Lai L; Wang X; Xiong J; Zhang X; Jiang J
Front Immunol; 2022; 13():996308. PubMed ID: 36275743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
